1. Home
  2. AAL vs HALO Comparison

AAL vs HALO Comparison

Compare AAL & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Airlines Group Inc.

AAL

American Airlines Group Inc.

N/A

Current Price

$13.79

Market Cap

9.6B

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$106.01

Market Cap

11.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AAL
HALO
Founded
1930
1998
Country
United States
United States
Employees
133700
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
11.2B
IPO Year
2004
2001

Fundamental Metrics

Financial Performance
Metric
AAL
HALO
Price
$13.79
$106.01
Analyst Decision
Buy
Buy
Analyst Count
18
11
Target Price
$15.59
$78.64
AVG Volume (30 Days)
58.2M
2.3M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
3.11
Revenue
$54,633,000,000.00
$151,862,000.00
Revenue This Year
$12.17
$28.24
Revenue Next Year
$4.62
$12.56
P/E Ratio
N/A
$34.12
Revenue Growth
0.78
N/A
52 Week Low
$10.09
$61.23
52 Week High
$18.79
$107.96

Technical Indicators

Market Signals
Indicator
AAL
HALO
Relative Strength Index (RSI) 36.19 76.65
Support Level $13.22 $67.12
Resistance Level $14.17 N/A
Average True Range (ATR) 0.42 3.46
MACD -0.20 0.81
Stochastic Oscillator 8.02 92.18

Price Performance

Historical Comparison
AAL
HALO

About AAL American Airlines Group Inc.

American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Dallas/Fort Worth, Charlotte, Chicago, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest average fleet of US legacy carriers.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: